Theodorescu, D <br/><br/>
p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate.  [electronic resource] 

 -  The Journal of urology  Jul 1997 
 - 131-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1097/00005392-199707000-00040  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--metabolism<br/>Adult<br/>Aged<br/>Biomarkers--analysis<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Recurrence, Local--epidemiology<br/>Predictive Value of Tests<br/>Prognosis<br/>Prostatic Neoplasms--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Retinoblastoma Protein--metabolism<br/>Survival Rate<br/>Time Factors<br/>Tumor Suppressor Protein p53--metabolism